Alex A Balekian1, Michael K Gould. 1. Division of Pulmonary and Critical Care, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. Alex.Balekian@med.usc.edu
Abstract
PURPOSE: Critically-ill patients with end-stage liver disease (ESLD) are at high risk for death during intensive care unit hospitalization, and currently available prognostic models have limited accuracy in this population. We aimed to identify variables associated with in-hospital mortality among critically ill ESLD patients and to develop and validate a simple, parsimonious model for bedside use. MATERIALS AND METHODS: We performed a retrospective chart review of 653 intensive care unit admissions for ESLD patients; modeled in-hospital mortality using multivariable logistic regression; and compared the predictive ability of several different models using the area under receiver operating characteristic (AU-ROC) curves. RESULTS: Multivariable predictors of in-hospital mortality included Model for End-stage Liver Disease (MELD) score, Acute Physiology and Chronic Health Evaluation (APACHE) II score, mechanical ventilation, and gender; there was also an interaction between MELD score and gender (P < .02). MELD alone had better discrimination (AU-ROC 0.83) than APACHE II alone (AU-ROC 0.76), and adding mechanical ventilation to MELD achieved the single largest increase in model discrimination (AU-ROC 0.85; P < .01). In a parsimonious, 2-predictor model, higher MELD scores (OR 1.14 per 1-point increase; 95% CI 1.11-1.16), and mechanical ventilation (OR 6.20; 95% CI 3.05-12.58) were associated with increased odds of death. Model discrimination was also excellent in the validation cohort (AU-ROC 0.90). CONCLUSIONS: In critically ill ESLD patients, a parsimonious model including only MELD and mechanical ventilation is more accurate than APACHE II alone for predicting in-hospital mortality. This simple bedside model can provide clinicians and patients with valuable prognostic information for medical decision-making.
PURPOSE:Critically-illpatients with end-stage liver disease (ESLD) are at high risk for death during intensive care unit hospitalization, and currently available prognostic models have limited accuracy in this population. We aimed to identify variables associated with in-hospital mortality among critically ill ESLDpatients and to develop and validate a simple, parsimonious model for bedside use. MATERIALS AND METHODS: We performed a retrospective chart review of 653 intensive care unit admissions for ESLD patients; modeled in-hospital mortality using multivariable logistic regression; and compared the predictive ability of several different models using the area under receiver operating characteristic (AU-ROC) curves. RESULTS: Multivariable predictors of in-hospital mortality included Model for End-stage Liver Disease (MELD) score, Acute Physiology and Chronic Health Evaluation (APACHE) II score, mechanical ventilation, and gender; there was also an interaction between MELD score and gender (P < .02). MELD alone had better discrimination (AU-ROC 0.83) than APACHE II alone (AU-ROC 0.76), and adding mechanical ventilation to MELD achieved the single largest increase in model discrimination (AU-ROC 0.85; P < .01). In a parsimonious, 2-predictor model, higher MELD scores (OR 1.14 per 1-point increase; 95% CI 1.11-1.16), and mechanical ventilation (OR 6.20; 95% CI 3.05-12.58) were associated with increased odds of death. Model discrimination was also excellent in the validation cohort (AU-ROC 0.90). CONCLUSIONS: In critically ill ESLDpatients, a parsimonious model including only MELD and mechanical ventilation is more accurate than APACHE II alone for predicting in-hospital mortality. This simple bedside model can provide clinicians and patients with valuable prognostic information for medical decision-making.
Authors: S J Thomson; C Moran; M L Cowan; S Musa; R Beale; D Treacher; M Hamilton; R M Grounds; T M Rahman Journal: Aliment Pharmacol Ther Date: 2010-04-29 Impact factor: 8.171
Authors: C Zauner; B Schneeweiss; B Schneider; C Madl; H Klos; A Kranz; K Ratheiser; L Kramer; K Lenz Journal: Eur J Gastroenterol Hepatol Date: 2000-05 Impact factor: 2.566
Authors: E Cholongitas; M Senzolo; D Patch; K Kwong; V Nikolopoulou; G Leandro; S Shaw; A K Burroughs Journal: Aliment Pharmacol Ther Date: 2006-04-01 Impact factor: 8.171
Authors: Robert P Myers; Abdel Aziz M Shaheen; Alexander I Aspinall; Robert R Quinn; Kelly W Burak Journal: J Hepatol Date: 2010-09-19 Impact factor: 25.083
Authors: Vincent Das; Pierre-Yves Boelle; Arnaud Galbois; Bertrand Guidet; Eric Maury; Nicolas Carbonell; Richard Moreau; Georges Offenstadt Journal: Crit Care Med Date: 2010-11 Impact factor: 7.598
Authors: P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim Journal: Hepatology Date: 2001-02 Impact factor: 17.425
Authors: M Müller; J C Schefold; A B Leichtle; D Srivastava; G Lindner; A K Exadaktylos; C A Pfortmueller Journal: Med Klin Intensivmed Notfmed Date: 2018-08-21 Impact factor: 0.840
Authors: Guowei Li; Lehana Thabane; Deborah J Cook; Renato D Lopes; John C Marshall; Gordon Guyatt; Anne Holbrook; Noori Akhtar-Danesh; Robert A Fowler; Neill K J Adhikari; Rob Taylor; Yaseen M Arabi; Dean Chittock; Peter Dodek; Andreas P Freitag; Stephen D Walter; Diane Heels-Ansdell; Mitchell A H Levine Journal: Ann Intensive Care Date: 2016-02-27 Impact factor: 6.925